KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Pacific Biosciences Of California (PACB) Receivables - Net (2016 - 2025)

Pacific Biosciences Of California (PACB) has 16 years of Receivables - Net data on record, last reported at $35.4 million in Q4 2025.

  • For Q4 2025, Receivables - Net rose 28.79% year-over-year to $35.4 million; the TTM value through Dec 2025 reached $35.4 million, up 28.79%, while the annual FY2025 figure was $35.4 million, 28.79% up from the prior year.
  • Receivables - Net reached $35.4 million in Q4 2025 per PACB's latest filing, up from $30.6 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $36.6 million in Q4 2023 and bottomed at $12.9 million in Q1 2021.
  • Average Receivables - Net over 5 years is $27.4 million, with a median of $28.6 million recorded in 2022.
  • Peak YoY movement for Receivables - Net: skyrocketed 115.81% in 2022, then fell 24.83% in 2024.
  • A 5-year view of Receivables - Net shows it stood at $24.2 million in 2021, then dropped by 22.5% to $18.8 million in 2022, then surged by 94.91% to $36.6 million in 2023, then fell by 24.83% to $27.5 million in 2024, then grew by 28.79% to $35.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $35.4 million in Q4 2025, $30.6 million in Q3 2025, and $32.3 million in Q2 2025.